|
Volumn 72, Issue 2, 2011, Pages 258-259
|
Omega-3 fatty acids and depression: From cellular mechanisms to clinical care
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACYL COENZYME A DESATURASE 1;
DOCOSAHEXAENOIC ACID;
FADS2 PROTEIN;
ICOSAPENTAENOIC ACID;
OMEGA 3 FATTY ACID;
OXYGENASE;
PLACEBO;
UNCLASSIFIED DRUG;
ADD ON THERAPY;
COMBINATION CHEMOTHERAPY;
DIET SUPPLEMENTATION;
DIETARY INTAKE;
DRUG DOSE COMPARISON;
DRUG EFFECT;
DRUG EFFICACY;
GENETIC POLYMORPHISM;
HUMAN;
IMMUNE RESPONSE;
MAJOR DEPRESSION;
METABOLIC SYNDROME X;
MONOTHERAPY;
MOOD DISORDER;
NONHUMAN;
OBESITY;
PRENATAL DRUG EXPOSURE;
PRIORITY JOURNAL;
PSYCHOPHARMACOTHERAPY;
REVIEW;
TERATOGENICITY;
ANIMALS;
BIPOLAR DISORDER;
BRAIN;
CLINICAL TRIALS AS TOPIC;
DEPRESSIVE DISORDER;
DEPRESSIVE DISORDER, MAJOR;
DOCOSAHEXAENOIC ACIDS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
EICOSAPENTAENOIC ACID;
FATTY ACIDS, OMEGA-3;
FEMALE;
HUMANS;
INFLAMMATION;
NEUROGENESIS;
PREGNANCY;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
SIGNAL TRANSDUCTION;
SYNAPTIC MEMBRANES;
TREATMENT OUTCOME;
|
EID: 79951995850
PISSN: 01606689
EISSN: None
Source Type: Journal
DOI: 10.4088/JCP.11ac06830 Document Type: Review |
Times cited : (32)
|
References (29)
|